The Lancet Retracts Decades-Old Paper on Talc Safety

The Lancet has retracted a paper published nearly fifty years ago that praised the safety of talc, the primary component in Johnson & Johnson's baby powder. Bloomberg posted on X, this retraction comes amid ongoing legal battles faced by the company, with tens of thousands of lawsuits alleging that the product caused cancer. The retraction of the study, which had been a reference point in defending the safety of talc, marks a significant development in the ongoing litigation. Johnson & Johnson has consistently denied the allegations, maintaining that its talc-based products are safe and do not cause cancer. The company has faced numerous lawsuits over the years, with plaintiffs claiming that the talc in its baby powder was contaminated with asbestos, a known carcinogen. The retraction of the paper could potentially impact the legal proceedings, as it removes a key piece of evidence previously used to support the safety claims of talc. Johnson & Johnson has already taken steps to address the concerns, including discontinuing the sale of talc-based baby powder in certain markets. The company continues to face scrutiny and legal challenges as it navigates the implications of the retraction and the ongoing lawsuits.